{"id":216,"date":"2015-01-30T17:49:28","date_gmt":"2015-01-30T22:49:28","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=216"},"modified":"2015-01-30T17:51:43","modified_gmt":"2015-01-30T22:51:43","slug":"ipo-weekly-recap-shake-shack-and-spark-therapeutics-shine","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-shake-shack-and-spark-therapeutics-shine\/","title":{"rendered":"IPO Weekly Recap: Shake Shack and Spark Therapeutics Shine"},"content":{"rendered":"<p>This past week ten IPOs debuted, six updated terms and zero new deals filed.<\/p>\n<p>Of the ten deals that came to market, two of them\u2014<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Shake%20Shack-SHAK\" target=\"_blank\"><strong>Shake Shack (NYSE: SHAK)<\/strong> <\/a>and <strong><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/SparkTherapeutics-ONCE\" target=\"_blank\">Spark Therapeutics (Nasdaq: ONCE)<\/a>\u2014<\/strong>closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs<!--more-->, who debuted on the same day, closed with more than a 100% gain on the same day of trading since July of 2000. Shake Shack priced ($21.00) above the already revised range, and opened at $47.00 for a 124% premium. \u2018SHAK\u2019 hit a high of 150% above the IPO price, $52.49, before closing its first day of trading at $45.90. Spark Therapeutics priced ($23.00) above the already revised range and opened at $45.10\u2014a 96% boost above the offering price. \u2018ONCE\u2019 hit a first day high of $51.90 before closing its opening day of trading at $50.00\u2014a 117% gainer for those who were allocated shares at the offering price. Five other deals this week returned double-digit percentage gains above their respective offering price upon opening. <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/AscendisPharma-ASND\" target=\"_blank\"><strong>Ascendis Pharma (Nasdaq: ASND)<\/strong> <\/a>opened $3.50 higher than the high-end $18.00 pricing for a respectful 19% gain. <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/EntellusMedical-ENTL\" target=\"_blank\"><strong>Entellus Medical (Nasdaq: ENTL)<\/strong><\/a> priced at the high end of the range, $17.00, and opened 13% higher with a $19.26 trade at first tick. \u2018ENTL\u2019 fared well in the aftermarket hitting a first week high of $22.63 or 33% above the IPO price. <strong><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/FlexPharma-FLKS\" target=\"_blank\">Flex Pharma (Nasdaq: FLKS)<\/a> <\/strong>upsized its IPO and priced above the range at $16.00. \u2018FLKS\u2019 opened $3.00 above the IPO price\u2014good for a 19% return\u2014however, the deal traded very poorly in the aftermarket and closed the first week of trading at $14.74 or 8% below the IPO price. <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/ZosanoPharmaCorporation-ZSAN-info.php\" target=\"_blank\"><strong>Zosano Pharma (Nasdaq: ZSAN)<\/strong><\/a> opened 11% above the $11.00 mid-range pricing but closed its first week of trading at $11.09. The lone REIT deal of the week, <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InfraREIT-HIFR\" target=\"_blank\"><strong>InfraREIT (NYSE: HIFR)<\/strong><\/a>, priced $2.00 above the range at $23.00. \u2018HIFR\u2019 opened $4.10 above the IPO price good for an 18% return above the offering price.<\/p>\n<p>Here is the <a href=\"http:\/\/www.ipoboutique.com\/blog\/ipo-week-ahead-schedule-week-of-february-2nd\/\" target=\"_blank\">IPO schedule<\/a> for the upcoming week:<\/p>\n<p><em><strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscribe now <\/a><\/strong>to get our full research report, IPO summary and senior managing partner Scott Sweet\u2019s ratings for this week. There are weekly, monthly and annual plans available.<br \/>\n<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This past week ten IPOs debuted, six updated terms and zero new deals filed. Of the ten deals that came to market, two of them\u2014Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE)\u2014closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[25,26,33,28,29,30,6],"class_list":["post-216","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-asnd","tag-entl","tag-flks","tag-hifr","tag-once","tag-shak","tag-zsan"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=216"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/216\/revisions"}],"predecessor-version":[{"id":221,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/216\/revisions\/221"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}